Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin.
about
The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation.Proteomic analysis of rat penile tissue in a model of erectile dysfunction after radical prostatectomy.The role of nitric oxide in penile erection.Oxygen free radicals and the penis.The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.The hidden impact of diabetes on male sexual dysfunction and fertility.Endothelial dysfunction in diabetic erectile dysfunction.Protective effect of resveratrol and quercetin on in vitro-induced diabetic mouse corpus cavernosumTime-dependent changes of erectile function in diabetic rats: role of systemic endothelial dysfunctionIncreased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis.Emerging gene and stem cell therapies for the treatment of erectile dysfunction.Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha.MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum.Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes.Glycosylated haemoglobin levels and the severity of erectile function in diabetic men.Hypercaloric Diet Establishes Erectile Dysfunction in Rat: Mechanisms Underlying the Endothelial Damage.
P2860
Q31720441-A4C187FD-B017-458A-87B9-77B5550DEACFQ33281555-9FE627A7-A02A-42DC-834A-692F045A40A5Q34240757-6F53B1A6-45D0-441B-B440-8417C4C9E771Q34706899-E47022ED-EA21-43C0-800D-9B09AEC8A4A6Q35055194-5BE415A1-483A-462E-83F5-D35E3ABD1047Q35582317-D3418E1F-2D45-4FAD-8F62-756221B19376Q36507302-E6B66FC1-640A-4D96-91E8-9CCA51523A39Q36700625-B809935A-DAED-4F75-90FF-4A4BF4387A1EQ36758102-0D67875E-E7DC-4A60-ABB5-212233637CBBQ37075004-5923BA0A-4619-492B-9960-3DF9D456EB29Q37692808-0FEBA666-1A0B-4E52-8B1F-DC0FC36D4F0DQ40234554-8E29959F-EFD8-4A61-823E-7408BEF0DFA6Q42524413-C58C0C5D-DC21-4685-9D72-2F7E01EA914AQ43543923-77741633-D20D-4EAD-9DC9-15CFEEBF960CQ43543926-272258B6-056B-47C1-A7FF-DA19D471CE76Q45260622-901158EC-6831-4E07-932A-77589A22AE0BQ46689586-ABDBC25F-D01A-4657-A465-63AC27FD20B6
P2860
Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@en
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@nl
type
label
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@en
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@nl
prefLabel
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@en
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@nl
P2093
P2860
P1433
P1476
Impairment of corpus cavernosa ...... lycosylated human haemoglobin.
@en
P2093
Cartledge JJ
Morrison JF
P2860
P304
P356
10.1046/J.1464-410X.2000.00599.X
P577
2000-04-01T00:00:00Z